StockData
Pluri Inc. logo

Pluri Inc. (PLUR) stock

PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$1.05−0.04 (-3.67%)

Close on Nov 13, 2026Market cap $12.96MP/E –Yield –

Pluri gross margin

Gross margin is gross profit as a percentage of revenue.

Pluri's gross margin for the twelve months ending Sep 30, 2026 was 52.0%. For fiscal 2026 it was 44.6%, against 49.0% the year before. The highest annual figure on record is 100.0% in fiscal 2020.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2026Jun 30, 202644.6%−4.4
FY2025Jun 30, 202549.0%−49.8
FY2024Jun 30, 202498.8%+1.9
FY2023Jun 30, 202396.9%−3.1
FY2022Jun 30, 2022100.0%+0.0
FY2020Jun 30, 2020100.0%+3.7
FY2019Jun 30, 201996.3%+0.3
FY2018Jun 30, 201896.0%−0.5
FY2016Jun 30, 201696.5%−0.1
FY2015Jun 30, 201596.6%−0.5
FY2014Jun 30, 201497.1%+0.0
FY2013Jun 30, 201397.1%−0.0
FY2012Jun 30, 201297.1%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ3 2026Sep 30, 202655.3%+18.9
Q4 FY2026CQ2 2026Jun 30, 202658.5%+6.5
Q3 FY2026CQ1 2026Mar 31, 202633.5%+1.7
Q2 FY2026CQ4 2025Dec 31, 202543.4%−16.6
Q1 FY2026CQ3 2025Sep 30, 202536.4%−25.0
Q4 FY2025CQ2 2025Jun 30, 202552.0%−43.8
Q3 FY2025CQ1 2025Mar 31, 202531.9%−68.1
Q2 FY2025CQ4 2024Dec 31, 202460.0%−40.0
Q1 FY2025CQ3 2024Sep 30, 202461.3%−38.7
Q4 FY2024CQ2 2024Jun 30, 202495.8%+0.2
Q3 FY2024CQ1 2024Mar 31, 2024100.0%+4.0
Q2 FY2024CQ4 2023Dec 31, 2023100.0%+0.0
Q1 FY2024CQ3 2023Sep 30, 2023100.0%+4.0
Q2 FY2020CQ4 2019Dec 31, 201995.7%–
Q2 FY2019CQ4 2018Dec 31, 201896.0%–
Q1 FY2019CQ3 2018Sep 30, 2018100.0%–
Q2 FY2018CQ4 2017Dec 31, 201796.0%–

More Pluri figures

See a number that looks wrong?